These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11997300)

  • 41. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
    Sajjan U; Reisman J; Doig P; Irvin RT; Forstner G; Forstner J
    J Clin Invest; 1992 Feb; 89(2):657-65. PubMed ID: 1737853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.
    Lim SZP; Fitzgerald DA
    Paediatr Respir Rev; 2018 Jun; 27():33-36. PubMed ID: 29033215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacterial lung infections in cystic fibrosis patients: an update.
    Chiappini E; Taccetti G; de Martino M
    Pediatr Infect Dis J; 2014 Jun; 33(6):653-4. PubMed ID: 24642521
    [No Abstract]   [Full Text] [Related]  

  • 47. Practical management of cystic fibrosis.
    Elborn JS
    Chron Respir Dis; 2006; 3(3):161-5. PubMed ID: 16916010
    [No Abstract]   [Full Text] [Related]  

  • 48. Identifying the killer in cystic fibrosis.
    Hearst JE; Elliott KE
    Nat Med; 1995 Jul; 1(7):626-7. PubMed ID: 7585137
    [No Abstract]   [Full Text] [Related]  

  • 49. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes.
    Zughaier SM; Ryley HC; Jackson SK
    Infect Immun; 1999 Mar; 67(3):1505-7. PubMed ID: 10024601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum.
    Middleton B; Rodgers HC; Cámara M; Knox AJ; Williams P; Hardman A
    FEMS Microbiol Lett; 2002 Jan; 207(1):1-7. PubMed ID: 11886742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virulence factors of Burkholderia cepacia.
    Nelson JW; Butler SL; Krieg D; Govan JR
    FEMS Immunol Med Microbiol; 1994 Feb; 8(2):89-97. PubMed ID: 7513590
    [No Abstract]   [Full Text] [Related]  

  • 53. Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.
    Clifton IJ; Peckham DG
    Expert Rev Respir Med; 2010 Aug; 4(4):519-29. PubMed ID: 20658913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in eucaryotic cell binding of Pseudomonas.
    Cervin MA; Simpson DA; Smith AL; Lory S
    Microb Pathog; 1994 Nov; 17(5):291-9. PubMed ID: 7536882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infections in patients with cystic fibrosis: diagnostic microbiology update.
    Gilligan PH
    Clin Lab Med; 2014 Jun; 34(2):197-217. PubMed ID: 24856524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteria-eating viruses could provide a route to stability in cystic fibrosis.
    Svoboda E
    Nature; 2020 Jul; 583(7818):S8-S9. PubMed ID: 32728257
    [No Abstract]   [Full Text] [Related]  

  • 58. [The influence of bacteria of the Burkholderia cepacia and Pseudomonas aeruginosa complex on cell-mediated immune reactions in experimental animals].
    Chernukha MIu; Nikolaeva TN; Shaginian IA; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):53-7. PubMed ID: 16028514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudomonas cepacia infection in cystic fibrosis.
    Smith DL; Smith EG; Gumery LB; Stableforth DE
    Lancet; 1992 Jan; 339(8787):252. PubMed ID: 1370564
    [No Abstract]   [Full Text] [Related]  

  • 60. [Microbiology and cystic fibrosis].
    Piédrola Angulo G
    An R Acad Nac Med (Madr); 2002; 119(2):343-62; discussion 362-6. PubMed ID: 12518659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.